worldwide locations | contacts | sitemap

 

 

 

 

Spotlight

Mark Fishman reflects on 10 years of NIBR
Mark Fishman started heading up research & development (R&D) at Novartis, as President of the Novartis Institutes for BioMedical Research (NIBR), 10 years ago.

 

Our people

With more than 6,000 scientists, physicians and business professionals around the world, we have an open, entrepreneurial and innovative culture that encourages collaboration as we work to push the boundaries of science to change the practice of medicine.

Focus on the patient, follow the science

At the earliest stages of Research, our drug discovery priorities are determined by patient need and sound science - not the potential market size of a medicine.

 

Research

 


NIBR Locations

NIBR Research Locations

Helpful links

Follow us

Novartis FacebookNovartis YouTube